Skip to content Skip to footer

New COVID Variant Found in South Africa Raises Concerns Over Impacts on Vaccine

Scientists are concerned about whether a new strain or future mutations could reduce vaccine efficacy.

Health workers prepare doses of the Pfizer-BioNTech COVID-19 vaccine inside the coronavirus disease vaccination centre set up at La Mostra D'Oltremare in Naples, Italy, on January 9, 2021.

Naturally, the coronavirus mutates as it spreads. But scientists are more concerned about some mutations more than others, and there’s one in particular that’s worrisome because it could throw a wrench in future vaccine efficacy.

Specifically, variant 20C/501Y.V2 — also known as B.1.351 lineage — which has emerged in Durban, South Africa, is alarming because the mutation of the virus is at the SARS-CoV-2 Spike, disguising its appearance to the immune system which can make it easier to bypass immune protection. Think of it like someone putting a wig on to go to a party they weren’t invited to, and tricking the bouncer by changing their appearance to enter.

“The concern is that it has a structural change that may change the shape of the Spike protein in a way that it may not be as easily recognized by the immune system, which means the antibodies that we raise through vaccination, as well as naturally occurring antibodies following a following infection,” explained Dr. George Rutherford, a professor of epidemiology at the University of California, San Francisco. “That’s the concern with that strain.”

Dean Blumberg, chief of pediatric infectious diseases and associate professor in the Department of Pediatrics at the University of California, Davis, agreed.

“We need to be immune to that spike protein to prevent infection. If it changes, if it mutates too much, then maybe we might lose immunity that we’ve achieved via either infection or immunization,” Blumberg said.

Variant 501Y.V2 is believed to be behind a fast-growing coronavirus outbreak in South Africa’s Eastern Cape Province. Researchers first identified the variant in October 2020 in Nelson Mandela Bay, South Africa. In December 2020, it was also identified in Zambia and appeared to be the dominant strain in the country. According to a preliminary data on the strain, samples of the variant carry up to 9 changes to the spike protein. One mutation of 501Y.V2 that is of concern is N501Y because of how the portion of the spike is mutated. A second mutation, dubbed E484K, appears to have changed the shape of the protein in a way that is making it harder for some antibodies to neutralize the virus.

“There are preliminary studies that suggest that people who’ve previously been infected with previous strains, they may neutralize the virus up to 10 times less,” Blumberg said. “So that’s a real concern, and that would suggest that maybe vaccine induced immunity may be escaped by this new variant in South Africa.”

Indeed, a paper published about this specific mutation this week echoed those concerns. One author of the paper told STAT News that, despite findings that that the virus was harder to neutralize with antibodies from other strains, the variant would have to have very specific mutations in certain spots to have a big impact on vaccine efficacy.

According to a separate report published this week, scientists tested the Pfizer vaccine against N501Y using blood samples from 20 people. Fortunately, the vaccination worked on them, but the sample size was far too small to say definitively that it would be true for the general population.

Does this strengthen the case that COVID-19 vaccines will be similar to the flu vaccine, in the sense that they will be tailored to different strains and more frequent?

“Maybe yes, maybe no,” Rutherford said. “But it would be quite unusual if we had to go in and change it this rapidly.”

The Centers for Disease and Control (CDC) has warned that the potential consequence of these mutations could be that these variants could evade vaccine immunity, but that it would not be an immediate impact.

“Both vaccination against and natural infection with SARS-CoV-2 produce a ‘polyclonal; response that targets several parts of the spike protein,” states the CDC. “The virus would likely need to accumulate multiple mutations in the spike protein to evade immunity induced by vaccines or by natural infection.”

Masking and social distancing still work to protect people from this strain, which hasn’t been identified in the United States yet. According to the BBC, it has been identified in Austria, Norway and Japan. Notably, there is no evidence to suggest that any of the mutations of this variant cause more serious illness.

“Currently, there is no evidence that these variants cause more severe illness or increased risk of death,” the CDC states. “New information about the virologic, epidemiologic, and clinical characteristics of these variants is rapidly emerging.”

Help us Prepare for Trump’s Day One

Trump is busy getting ready for Day One of his presidency – but so is Truthout.

Trump has made it no secret that he is planning a demolition-style attack on both specific communities and democracy as a whole, beginning on his first day in office. With over 25 executive orders and directives queued up for January 20, he’s promised to “launch the largest deportation program in American history,” roll back anti-discrimination protections for transgender students, and implement a “drill, drill, drill” approach to ramp up oil and gas extraction.

Organizations like Truthout are also being threatened by legislation like HR 9495, the “nonprofit killer bill” that would allow the Treasury Secretary to declare any nonprofit a “terrorist-supporting organization” and strip its tax-exempt status without due process. Progressive media like Truthout that has courageously focused on reporting on Israel’s genocide in Gaza are in the bill’s crosshairs.

As journalists, we have a responsibility to look at hard realities and communicate them to you. We hope that you, like us, can use this information to prepare for what’s to come.

And if you feel uncertain about what to do in the face of a second Trump administration, we invite you to be an indispensable part of Truthout’s preparations.

In addition to covering the widespread onslaught of draconian policy, we’re shoring up our resources for what might come next for progressive media: bad-faith lawsuits from far-right ghouls, legislation that seeks to strip us of our ability to receive tax-deductible donations, and further throttling of our reach on social media platforms owned by Trump’s sycophants.

We’re preparing right now for Trump’s Day One: building a brave coalition of movement media; reaching out to the activists, academics, and thinkers we trust to shine a light on the inner workings of authoritarianism; and planning to use journalism as a tool to equip movements to protect the people, lands, and principles most vulnerable to Trump’s destruction.

We urgently need your help to prepare. As you know, our December fundraiser is our most important of the year and will determine the scale of work we’ll be able to do in 2025. We’ve set two goals: to raise $86,000 in one-time donations and to add 1260 new monthly donors by midnight on December 31.

Today, we’re asking all of our readers to start a monthly donation or make a one-time donation – as a commitment to stand with us on day one of Trump’s presidency, and every day after that, as we produce journalism that combats authoritarianism, censorship, injustice, and misinformation. You’re an essential part of our future – please join the movement by making a tax-deductible donation today.

If you have the means to make a substantial gift, please dig deep during this critical time!

With gratitude and resolve,

Maya, Negin, Saima, and Ziggy